Prevalence and Risk Factors of Baseline Plasmodium Infection before the First Seasonal Malaria Chemoprevention Round in Burkina Faso: A Cross-Sectional Study

Abstract

Background: Malaria parasite carriage represents a hidden reservoir that sustains transmission and may undermine the effectiveness of control strategies such as seasonal malaria chemoprevention (SMC). Quantifying the prevalence and risk factors of parasite carriage prior to SMC delivery could provide essential baseline data for assessing the impact of the intervention and optimizing its implementation. Methods: A cross-sectional survey was conducted in July 2025, 0 to 4 days before delivery of the first round of SMC. Children were randomly selected from ten villages in the Nanoro Health and Demographic Surveillance System (HDSS). Capillary blood was collected by finger prick to prepare thick and thin blood smears, which were examined later by light microscopy to detect Plasmodium species carriage. Socio-demographic and household characteristics were extracted from the HDSS database. Associations between covariates including child age, sex, mid upper arm circumference, household head education, malaria prevention practices, and household wealth quintile and Plasmodium carriage were assessed using modified Poisson regression with robust variance, fitted with generalized estimating equations to estimate prevalence ratios and 95% confidence intervals. An exchangeable working correlation structure was specified, with clustering at the household level to account for intra household intra correlation. Results: Among 1,643 enrolled children with microscopy results, the prevalence of Plasmodium carriage was 25.5% (95% CI: 23.5% - 27.7%) and that of gametocyte carriage was 2.2% (95% CI: 1.6 - 3.1). Compared to children aged < 1 year, the risk of carriage was higher in those aged 2 - 3 years (aPR 3.03; 95% CI: 1.98 - 4.63), and 3 - 4 years (aPR 3.43; 95% CI: 2.25 - 5.23). Male children had higher prevalence ratio than females (aPR = 1.21; 95% CI: 1.03 - 1.42). Conclusion: Prior to SMC campaign, Plasmodium carriage was prevalent among children in Nanoro, with older children exhibiting significantly higher risk. These findings emphasize the relevance of SMC intervention at that period of the year and complementary interventions, such as vaccination and targeted health education, alongside the SMC implementation. This baseline data informs tailored strategies in high-transmission settings.

Share and Cite:

Rouamba, T. , Kabore, B. , Sondo, P. , Bouda, I. , Hien, F. , Maïga, W. , Millogo, S. , Bayala, I. , Tapsoba, A. , Compaore, E. , Derra, K. , Ouedraogo, S. and Tinto, H. (2026) Prevalence and Risk Factors of Baseline Plasmodium Infection before the First Seasonal Malaria Chemoprevention Round in Burkina Faso: A Cross-Sectional Study. Open Journal of Epidemiology, 16, 337-351. doi: 10.4236/ojepi.2026.162025.

1. Introduction

Malaria remains one of the leading causes of morbidity and mortality in sub-Saharan Africa, disproportionately affecting children under five years of age. In 2024, the World Health Organization (WHO) reported an estimated 249 million malaria cases and 608,000 deaths, with more than 94% occurring in Africa [1]. Burkina Faso is among the highest-burden countries, reporting an incidence of approximately 400 cases per 1000 population per year, and malaria continues to be the primary cause of outpatient consultations and childhood mortality [1] [2].

Over the past two decades, Burkina Faso has introduced multiple malaria control strategies to reduce transmission. These include the large-scale deployment of long-lasting insecticide-treated nets (LLITNs), expanded access to rapid diagnostic tests (RDTs), artemisinin-based combination therapies (ACTs), and the implementation of seasonal malaria chemoprevention (SMC) for children aged 3 - 59 months since 2014 [3] [4]. The latter has demonstrated high protective efficacy, reducing clinical malaria episodes by up to 75% when correctly administered [5]. In addition, malaria vaccination (RTS, S and R21) is now part of the national malaria control tools [6] [7]. Importantly, combining the malaria vaccine with SMC has been shown to yield greater protection than either intervention alone, reducing clinical malaria by 62% and severe malaria by 70% in a West African trial [8].

Despite these advances, Plasmodium infections remain widespread. These silent infections, common among young children in the Sahel, can account for 20% - 40% parasite prevalence at the onset of the rainy season [9]-[12]. Children who carry parasites contribute to the sustainability of malaria transmission and may experience breakthrough infections [13] despite the deployment of preventive measures. When SMC is not effective in clearing parasites, either because of poor adherence or non-compliance, these persistent infections may progress to clinical malaria [14] [15], which, if not promptly treated, can evolve into severe disease with life-threatening consequences [16] [17]. Such residual carriage may ultimately reduce the apparent impact of SMC or vaccination by sustaining the parasite reservoir and enabling progression to illness [16].

Understanding the prevalence and determinants of Plasmodium parasite carriage (Plasmodium infection) prior to SMC campaigns is therefore critical. Baseline parasitemia may be useful for understanding short-term SMC effectiveness, identifying higher-risk groups such as older preschool children, and informing the integration of emerging tools, including malaria vaccines, into national malaria control strategies. In fact, a recent study in Northern Cameroon and southern Senegal reported a high baseline prevalence of RDT-confirmed asymptomatic P. falciparum infections prior to the SMC implementation [18]. In the context of large-scale SMC deployment, the protective impact against clinical malaria was high when coverage was adequate, but real-world constraints may reduce the effectiveness and maintain a reservoir of asymptomatic infections [19].

This study aimed to estimate the prevalence of Plasmodium infection by microscopy among children (6 to 59 months) prior to the first SMC round and to identify demographic and household determinants of Plasmodium infections.

2. Methods

2.1. Study Design and Setting

A cross-sectional survey was conducted in July 2025, within 0 - 4 days preceding the first Seasonal Malaria Chemoprevention (SMC) round. The study was carried out in the Nanoro Health District in Burkina Faso, an area of intense seasonal malaria transmission with peaks between July and October. Ten villages from Soaw department located in the Nanoro Health and Demographic Surveillance System (HDSS) catchment area were included. This survey was nested within the MalNut Project, a multi-component randomized controlled trial designed to prevent malnutrition and malaria in children aged 6 to 59 months in Burkina Faso by combining SMC with nutritional supplementation (PACTR202507830860741). In the parent trial, eligible children were to be randomly allocated to receive either SMC + Plumpy Doz®, SMC + Nutributter Plus®, or standard intervention (only SMC).

2.2. Study Population and Sampling

Prior to treatment allocation and initiation of the intervention, households were identified from the HDSS database and screened for eligibility. Following the recruitment strategy of the parent trial, households with one eligible child (6 - 59 months) were selected first; if the target sample size for the main trial had not yet been reached, households with two eligible children were subsequently included until the required sample size was attained. During the household visit, all eligible children present in the selected households were assessed. For children presenting with malaria-related symptoms, a blood smear was collected before referral to the nearest health facility for clinical evaluation and appropriate management.

2.3. Data Collection

Data were collected using a structured electronic questionnaire developed in REDCap (Research Electronic Data Capture), administered by trained field workers during household visits. Socio-demographic and household variables, including household head education and occupation, household wealth quintile, and geographical coordinates, were extracted from the HDSS database.

Information on malaria prevention practices (use of insecticide-treated nets, mosquito coil burning, and indoor insecticide spraying), anthropometric measurements (mid-upper arm circumference, weight, height), and axillary temperature were collected during the home visit.

Capillary blood was collected by trained nurses to prepare thick smears and to measure hemoglobin concentration. Microscopy slides were read independently by two certified microscopists, and any discrepancies were resolved by a senior expert reader.

2.4. Variables Definition

Primary outcome

The primary outcome was asymptomatic Plasmodium infection, defined as the detection of asexual parasites by microscopy in the absence of declared malaria-related symptoms. Because all blood smears were collected during household visits, outside of health facilities, and without care-seeking by participants, all microscopy-positive cases identified in the survey were classified as asymptomatic carriers. Secondary outcome was the prevalence of gametocyte carriage.

Exposure variables

The main exposure variables included child age and sex, household wealth quintile, head-of-household occupation, and education. Household wealth quintiles were derived from HDSS socioeconomic data using a routine asset-based household wealth index and classified into five ordered categories, from lowest to highest.

2.5. Statistical Analysis

Descriptive statistics were used to summarize household and participant characteristics, malaria-prevention practices, and the prevalence of asymptomatic infection with corresponding 95% confidence intervals (95% CI). To assess factors associated with asymptomatic Plasmodium infection, modified Poisson regression with robust variance estimation, implemented through generalized estimating equations (GEE) was used to estimate prevalence ratios and their 95% confidence intervals. This approach was selected because the outcome (asymptomatic infection) was relatively common in the study population, and logistic regression would therefore overestimate the risk by yielding odds ratios that diverge from the true risk ratio. The modified Poisson model, as described by Zou (2004), provides direct and interpretable estimates of prevalence ratios, which are more appropriate than odds ratios for cross-sectional studies with binary outcomes. The use of a robust sandwich variance estimator corrects for potential misspecification of the Poisson variance structure, ensuring valid standard errors even when the equidispersion assumption is not met. Because children were clustered within both households and villages, correlation was assessed at both levels. The intravillage correlation was low (ICC = 0.008), whereas the intrahousehold correlation was more substantial (ICC = 0.156). Therefore, the primary analysis accounted for clustering at the household level using a GEE framework with an exchangeable working correlation structure. The model was adjusted with number of prevention practices, mid-upper arm circumference (MUAC), village, number of households, and household size All analyses were conducted using R version 4.5.1 (2025-06-13 ucrt).

3. Results

3.1. Household Characteristics of Enrolled Children

Most households had one infant (910, 73.7%), followed by two infants (246, 19.9%), three infants (60, 4.9%), four infants (15, 1.2%), and five infants (4, 0.3%), indicating that households with multiple infants were relatively uncommon. Household characteristics (n = 1235) were broadly similar across all age groups. Children lived in large households, with a median of 10 members overall. Wealth distribution was balanced across age categories, with most of the households falling into the middle and upper wealth quintiles. The majority of household heads were engaged in agriculture (77.2%), and formal employment (i.e. Commerce, Crafts, Farming) was rare (2.3%). Educational attainment was low across all groups, with approximately 89.7% of household heads having no formal schooling. Overall, the socioeconomic profile of participating households was relatively homogeneous (Table 1).

Table 1. Household characteristics of enrolled children by age category.

Characteristic

<1 year

[1 - 2) years

[2 - 3) years

[3 - 4] years

Overall

(N = 88)

(N = 343)

(N = 398)

(N = 406)

(N = 1235)

Number of households within the compound

Mean (SD)

2.74 (1.83)

2.92 (2.14)

3.02 (2.53)

3.14 (2.34)

3.01 (2.32)

Median [Min, Max]

2.93 [1.00, 11.0]

2.93 [1.00, 17.0]

2.00 [1.00, 17.0]

2.93 [1.00, 17.0]

2.93 [1.00, 17.0]

Number of members per household

Mean (SD)

10.8 (5.75)

9.90 (6.59)

10.5 (6.94)

10.7 (6.67)

10.4 (6.68)

Median [Min, Max]

11.5 [1.00, 32.0]

10.0 [1.00, 65.0]

10.0 [1.00, 70.0]

10.0 [1.00, 39.0]

10.0 [1.00, 70.0]

Wealth quintile

Lowest

27 (30.7%)

80 (23.3%)

64 (16.1%)

62 (15.3%)

233 (18.9%)

Second

13 (14.8%)

44 (12.8%)

57 (14.3%)

44 (10.8%)

158 (12.8%)

Third

13 (14.8%)

52 (15.2%)

74 (18.6%)

75 (18.5%)

214 (17.3%)

Fourth

18 (20.5%)

87 (25.4%)

114 (28.6%)

125 (30.8%)

344 (27.9%)

Highest

17 (19.3%)

80 (23.3%)

89 (22.4%)

100 (24.6%)

286 (23.2%)

Household head occupation

Agriculture

69 (78.4%)

264 (77.0%)

306 (76.9%)

315 (77.6%)

954 (77.2%)

None/Other

12 (13.6%)

44 (12.8%)

52 (13.1%)

56 (13.8%)

164 (13.3%)

Small-scale work

6 (6.8%)

28 (8.2%)

25 (6.3%)

30 (7.4%)

89 (7.2%)

Formal job

1 (1.1%)

7 (2.0%)

15 (3.8%)

5 (1.2%)

28 (2.3%)

Household head education

No education

67 (76.1%)

310 (90.4%)

358 (89.9%)

373 (91.9%)

1108 (89.7%)

Primary

15 (17.0%)

16 (4.7%)

18 (4.5%)

21 (5.2%)

70 (5.7%)

Secondary or higher

6 (6.8%)

17 (5.0%)

22 (5.5%)

12 (3.0%)

57 (4.6%)

3.2. Baseline Demographic and Anthropometric Characteristics

Among 1662 children from 1235 household visited before the SMC campaign, anthropometric indicators such as weight, height, and MUAC increased consistently with age, reflecting expected developmental patterns (Table 2). The overall prevalence of fever (axillary temperature ≥ 37.5) was low (2.5%), with minimal variation across age groups, suggesting limited symptomatic infection at baseline.

Table 2. Baseline demographic and anthropometric characteristics of children by age group.

<1 year

[1 - 2) years

[2 - 3) years

[3 - 4] years

Overall

(N = 171)

(N = 510)

(N = 495)

(N = 486)

(N = 1662)

Age (months)

Mean (SD)

0.80 (0.11)

1.51 (0.27)

2.49 (0.28)

3.48 (0.27)

2.31 (0.96)

Median [Min, Max]

0.80 [0.59, 0.99]

1.51 [1.00, 1.99]

2.52 [2.00, 2.99]

3.52 [3.00, 3.99]

2.29 [0.59, 4.00]

Sex

Female

81 (47.4%)

254 (49.8%)

247 (49.9%)

240 (49.4%)

822 (49.5%)

Male

90 (52.6%)

256 (50.2%)

248 (50.1%)

246 (50.6%)

840 (50.5%)

Temperature (˚C)

Mean (SD)

36.4 (0.544)

36.4 (0.583)

36.3 (0.587)

36.4 (0.602)

36.4 (0.586)

Median [Min, Max]

36.4 [35.0, 37.8]

36.4 [35.0, 39.1]

36.3 [35.0, 39.4]

36.4 [35.0, 39.2]

36.3 [35.0, 39.4]

Fever (Temperature ≥ 37.5˚)

Fever

3 (1.8%)

15 (2.9%)

11 (2.2%)

12 (2.5%)

41 (2.5%)

No fever

168 (98.2%)

495 (97.1%)

484 (97.8%)

474 (97.5%)

1621 (97.5%)

Weight (kg)

Mean (SD)

8.49 (7.84)

9.11 (1.45)

10.8 (1.86)

12.3 (2.21)

10.5 (3.37)

Median [Min, Max]

7.60 [5.20, 109]

9.00 [5.30, 16.6]

10.9 [5.70, 19.0]

12.5 [6.20, 19.9]

10.1 [5.20, 109]

Height (cm)

Mean (SD)

69.4 (4.86)

75.7 (5.65)

82.5 (6.50)

89.0 (8.09)

81.0 (9.25)

Median [Min, Max]

69.0 [50.0, 88.0]

75.0 [60.0, 97.0]

83.0 [62.0, 102]

91.0 [64.0, 115]

80.0 [50.0, 115]

MUAC (cm)

Mean (SD)

13.9 (0.937)

14.0 (0.938)

14.4 (0.964)

14.8 (0.954)

14.4 (1.02)

Median [Min, Max]

13.7 [12.0, 17.0]

14.0 [10.1, 17.0]

14.4 [11.0, 18.2]

15.0 [13.0, 18.2]

14.2 [10.1, 18.2]

3.3. Utilization Patterns of Malaria Prevention Tools among Children in Nanoro

Figure 1 shows a strong predominance of insecticide-treated net (ITN) use among children in the study population. ITNs were the most commonly reported malaria prevention tool, with 1367 children using ITNs alone, and 1660 ITN reports overall when combinations with other tools were included. By contrast, the other prevention tools were much less frequently reported, including approximately 285 reports each for coil burning and other tools, 158 for spray use, and 146 for repellent gel cream. This UpSet plot further indicates that the vast majority of children relied on a single prevention method, overwhelmingly ITN use alone, whereas only a small minority reported combinations of multiple tools.

Figure 1. Utilization patterns of malaria prevention tools among children in Nanoro.

3.4. Prevalence of Malaria in the Study Population

The overall prevalence of malaria infection in the study population was 25.5% (95% CI: 23.5% - 27.7%). The prevalence of asymptomatic Plasmodium infections increased sharply with age. Infants under 1 year had a relatively low prevalence of 12.3% (95% CI: 8.2% - 18.0%), and children aged 1 - 2 years showed a similar level at 12.9% (95% CI: 10.3% - 16.1%). However, infection prevalence rose noticeably in older age groups. Among children aged 2 - 3 years, nearly one-third were infected (32.7%), and the highest prevalence was observed in those aged 3 - 4 years at 36.0% (Table 3).

Table 3. The prevalence of asymptomatic Plasmodium infections according to the age group.

Age category

Positive

Total

Prevalence (95% CI)

All population

424

1662

25.5% (23.5%, 27.7%)

<1 year

21

171

12.3% (8.2%, 18.0%)

[1 - 2) years

66

510

12.9% (10.3%, 16.1%)

[2 - 3) years

162

495

32.7% (28.7%, 37.0%)

[3 - 4] years

175

486

36.0% (31.9%, 40.4%)

Figure 2 shows the distribution of log-transformed parasitemia levels across different age classes among children with positive parasitemia. Overall, parasitemia levels were significantly higher in older age groups. Children aged < 1 year and those between 1 - 2 years had lower median parasite densities compared to children aged 2 - 3 years and 3 - 4 years, who showed markedly higher and more variable parasitemia levels. This trend suggests increasing exposure and parasite burden with age.

Figure 2. Distribution of log-transformed parasitemia levels across different age classes among children with positive parasitemia.

It was noticeable that gametocyte carriage was detected in 2.2% of the study population (95% CI: 1.6 - 3.1).

3.5. Factors Associated with Malaria Infection

In adjusted analyses, age was the strongest factor associated with parasite prevalence. Compared with infants < 1 year, children aged 1 - 2 years showed no difference in prevalence (PR = 1.14; 95% CI: 0.71 - 1.83), whereas those aged 2 - 3 years (PR = 3.03; 95% CI: 1.98 - 4.63) and 3 - 4 years (PR = 3.43; 95% CI: 2.25 - 5.23) had almost a threefold higher prevalence (Table 4). Male children had higher prevalence than females (PR = 1.21; 95% CI: 1.03 - 1.42).

No significant associations were observed for nutritional status (MUAC), household composition (number of households or household size), socioeconomic status (wealth quintile), head-of-household occupation, or education level. Similarly, the number of prevention practices used did not show a measurable association with parasite prevalence.

Table 4. Multivariable modified Poisson regression identifying factors associated with asymptomatic malaria infection.

Characteristic

N

n

PR

95% CI

p-value

Age category

<1 year (ref)

171

21

1

[1 - 2) years

510

66

1.14

0.71, 1.83

0.6

[2 - 3) years

495

162

3.03

1.98, 4.63

<0.001

[3 - 4] years

486

175

3.43

2.25, 5.23

<0.001

Sex

Female

822

190

1

Male

840

234

1.21

1.03, 1.42

0.023

Axillary Temperature ≥ 37.5

No

1621

408

1

Yes

41

16

1.49

1.00, 2.24

0.052

Wealth quintile

Fourth (ref)

468

132

1

Highest

436

108

0.91

0.72, 1.14

0.4

Lowest

277

70

0.98

0.76, 1.27

0.9

Second

194

43

0.82

0.60, 1.13

0.2

Third

287

71

0.85

0.66, 1.11

0.2

Head of household occupation

Agriculture (ref)

1299

323

1

Formal job

34

10

1.53

0.72, 3.24

0.3

None/Other

214

59

1.07

0.84, 1.37

0.6

Small-scale work

115

32

1.17

0.86, 1.58

0.3

Head of household education

No education (ref)

1499

382

1

Primary

94

26

1.17

0.83, 1.63

0.4

Secondary or higher

69

16

0.79

0.42, 1.49

0.5

Adjusted with Village, Number of prevention practices, Mid-upper arm circumference (MUAC), Number of households, and Household size.

4. Discussion

This study shows that the overall prevalence of infections was substantial, and older pre-school children carried a disproportionate burden of asymptomatic parasitemia. Age-related gradients similar to those observed here have been consistently documented across the Sahel region, where parasite carriage typically ranges from 20% to 40% at the start of the rainy season [9]-[12] [20]. Infants exhibited the lowest prevalence, likely reflecting protection from residual maternal antibodies, lower mobility, and closer household head/caregiver protection [21]-[23]. In contrast, increased independence, outdoor activity, and cumulative exposure may explain the sharp increase in infection among children older than two years, consistent with longitudinal studies from several sub-Saharan African countries [20] [24].

The high prevalence of parasitemia observed nearly before the SMC delivery has important operational implications. The protective efficacy of SP–AQ depends on both clearance of existing parasitemia and short-term chemoprophylaxis [19] [25] [26]. A large baseline reservoir may reduce the observable impact of SMC if parasites are not fully cleared due to incomplete adherence, suboptimal dosing, vomiting, or chemoprophylactic failure [25]. Persistent parasitemia at the time of SMC administration has been associated with increased risk of breakthrough malaria during the same transmission season [14]. If untreated, such infections may progress from asymptomatic to clinical malaria, and eventually to severe disease, especially in younger children [14] [15]. These findings highlight the need for improved adherence monitoring, community counselling, and pharmacovigilance during SMC campaigns.

The detection of gametocytes (2.6%) provides further evidence of sustained transmission potential despite preventive measures. Even low-density gametocytemia is sufficient to infect mosquitoes and perpetuate the transmission between SMC cycles [27]. These results support the need to reinforce integrated vector management, particularly ITN durability, replacement campaigns, and complementary strategies addressing outdoor or early-evening biting, which has been increasingly documented in West Africa [28].

Importantly, children older than three years had the highest prevalence and parasite densities, suggesting that this age group represents a particularly important reservoir. Although still eligible for SMC, their increasing exposure and waning maternal immunity may reduce the relative protection provided by chemoprevention alone. Evidence from recent West African trials shows that combining SMC with malaria vaccination (RTS, S/AS01 or R21/Matrix-M) yields additive protection and substantially reduces clinical malaria by more than 60% [6] [8] [29] [30]. Vaccination of this older pre-school group may therefore enhance protection during the high-risk period when exposure intensifies.

No socioeconomic or household-level characteristics were associated with infection risk, likely reflecting the relative socioeconomic homogeneity of rural Nanoro. The lack of association with malaria prevention practices, dominated by reported ITN use, probably reflects behavioral and entomological factors rather than absence of effect [31]. In Burkina Faso, substantial outdoor and early evening vector biting could limit ITN protection, which is largely confined to indoor sleeping hours. As a result, an estimated 10 percent of malaria transmission persists despite high ITN coverage, occurring when human activity overlaps with vector exposure outside net use [31]. In addition, self-reported ITN use often overestimates actual protection by 8 to 13.6 percent, potentially biasing assessments of ITN effectiveness [32] [33]. These findings highlight the persistence of residual transmission and the need for complementary malaria control strategies.

This study has several strengths. HDSS-linked random sampling ensured strong population representativeness, while data collection conducted immediately prior to the SMC implementation enabled an accurate estimation of baseline infection prevalence. The use of GEE-based modified Poisson regression provided valid population-averaged effect estimates and appropriately accounted for within-village clustering. Nevertheless, some limitations should be considered. Microscopy may have underestimated the true prevalence by missing sub-patent infections detectable only by molecular methods such as PCR. The cross-sectional design captures infection status at a single time point, precluding assessment of temporal dynamics or causality. In addition, malaria prevention practices were self-reported and therefore subject to recall and social desirability bias.

Despite these limitations, the study provides valuable insights into the asymptomatic malaria reservoir in a high-burden Sahelian setting and underscores the need to adapt malaria control strategies, particularly for older pre-school children who remain highly exposed despite their eligibility for seasonal malaria chemoprevention.

5. Conclusions

Asymptomatic Plasmodium infections were highly prevalent among children under five in Nanoro immediately before the 2025 SMC cycle, with older pre-school children being the main reservoir of infection and transmission. Age was the main determinant of infection risk, whereas socioeconomic and household characteristics showed no meaningful influence. These findings underscore the need to strengthen malaria control strategies for children aged 2 - 4 years, who experience increasing exposure but remain incompletely protected by SMC alone.

Enhanced community-based surveillance, improved adherence monitoring during SMC, and reinforcement of ITN and vector management strategies are essential to reduce the asymptomatic reservoir. Integrating malaria vaccination with SMC could provide additional protection, particularly for older pre-school children who carry the highest burden of the infection. This baseline assessment will be critical for evaluating the impact of the MalNut intervention and guiding future malaria control strategies in Burkina Faso.

Ethics Approval and Consent to Participate

The study was approved by the ethic committee of Burkina Faso (Comité d’Ethique pour la Recherche en Santé, n˚2024-10-308). Written informed consent was obtained from parents or legal guardians prior to participation.

Availability of Data and Materials

The datasets generated and/or analysed during the current manuscript are not publicly available due to ethical and confidentiality restrictions but are available from the corresponding author on reasonable request, subject to institutional approval and applicable data-sharing regulations.

Funding

This work was conducted within the framework of the MalNut study and was funded by EDESIA. The funder supported the implementation of the study but had no role in the analysis and interpretation of the data or in the writing of the manuscript, unless otherwise stated.

Authors’ Contributions

TR conceived the analysis idea, conducted the statistical analysis, interpreted the data, and drafted the first version of the manuscript. HT, SO, PS and BK contributed to study design and supervision of field implementation. IB, MKS, WEC WGM and KD contributed to data collection and laboratory procedures. HT, PS and BK contributed to data interpretation and critical revision of the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We sincerely thank the children and their parents or legal guardians for participating in this study. We are also grateful to the field workers, microscopists, data management staff, and community leaders in the Nanoro health district for their valuable support during study implementation. We acknowledge the support of the Clinical Research Unit of Nanoro and all members of the MalNut study team for their contribution to the conduct of this work.

Declaration of Generative AI and AI-Assisted Technologies

The authors used ChatGPT (OpenAI) solely for English language editing and improvement of writing clarity. All scientific content, interpretation, and conclusions were developed and validated by the authors.

Conflicts of Interest

The authors declare that they have no competing interests.

References

[1] World Health Organization (2024) WHO Team Global Malaria Programme. World Malaria Report 2024: Key Facts and Figures. 316.
[2] Ministère de la Santé et de l’Hygiène Publique (2024) Annuaire Statistique (Burkina Faso).
[3] PNLP Burkina Faso (2021) Directives nationales de prise en charge du paludisme.
[4] Secrétariat Permanent pour l’élimination du Paludisme—SP/Palu (2020) Plan Stratégique National pour l’élimination du paludisme au Burkina Faso 2021-2025.
[5] Baba, E., Hamade, P., Kivumbi, H., Marasciulo, M., Maxwell, K., Moroso, D., et al. (2020) Effectiveness of Seasonal Malaria Chemoprevention at Scale in West and Central Africa: An Observational Study. The Lancet, 396, 1829-1840.[CrossRef] [PubMed]
[6] World Health Organization & Partners (2023) Strategic Advisory Group of Experts (SAGE) on Immunization Evidence to Recommendations Framework 1.
[7] RTS SCTP (2015) Efficacy and Safety of RTS,S/AS01 Malaria Vaccine with or without a Booster Dose in Infants and Children in Africa: Final Results of a Phase 3, Individually Randomised, Controlled Trial. The Lancet, 386, 31-45.
[8] Chandramohan, D., Zongo, I., Sagara, I., Cairns, M., Yerbanga, R., Diarra, M., et al. (2021) Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention. New England Journal of Medicine, 385, 1005-1017.[CrossRef] [PubMed]
[9] Sondo, P., Kaboré, B., Rouamba, T., Compaoré, E., Tibiri, Y.N.G., Kaboré, H.A.L.F., et al. (2023) Enhanced Effect of Seasonal Malaria Chemoprevention When Coupled with Nutrients Supplementation for Preventing Malaria in Children under 5 Years Old in Burkina Faso: A Randomized Open Label Trial. Malaria Journal, 22, Article No. 315.[CrossRef] [PubMed]
[10] Nankabirwa, J., Wandera, B., Kiwanuka, N., Staedke, S.G., Kamya, M.R. and Brooker, S.J. (2013) Asymptomatic Plasmodium Infection and Cognition among Primary Schoolchildren in a High Malaria Transmission Setting in Uganda. The American Society of Tropical Medicine and Hygiene, 88, 1102-1108.[CrossRef] [PubMed]
[11] Agaba, B.B., Rugera, S.P., Mpirirwe, R., Atekat, M., Okubal, S., Masereka, K., et al. (2022) Asymptomatic Malaria Infection, Associated Factors and Accuracy of Diagnostic Tests in a Historically High Transmission Setting in Northern Uganda. Malaria Journal, 21, Article No. 392.[CrossRef] [PubMed]
[12] Hayuma, P.M., Wang, C.W., Liheluka, E., Baraka, V., Madebe, R.A., Minja, D.T.R., et al. (2021) Prevalence of Asymptomatic Malaria, Submicroscopic Parasitaemia and Anaemia in Korogwe District, North-Eastern Tanzania. Malaria Journal, 20, Article No. 424.[CrossRef] [PubMed]
[13] Ahmad, A., Mohammed, N.I., Joof, F., Affara, M., Jawara, M., Abubakar, I., et al. (2023) Asymptomatic Plasmodium falciparum Carriage and Clinical Disease: A 5-Year Community-Based Longitudinal Study in the Gambia. Malaria Journal, 22, Article No. 82.[CrossRef] [PubMed]
[14] Sanogo, D., Toure, M., Keita, M., Kane, F., Keita, S., Sanogo, I., et al. (2025) High Incidence of Clinical Malaria among Asymptomatic Plasmodium falciparum Infected Children Receiving SMC with Sulfadoxine-Pyrimethamine and Amodiaquine (SP + AQ) in Koulikoro, Mali. Malaria Journal, 24, Article No. 102.[CrossRef] [PubMed]
[15] Sumner, K.M., Mangeni, J.N., Obala, A.A., Freedman, E., Abel, L., Meshnick, S.R., et al. (2021) Impact of Asymptomatic Plasmodium falciparum Infection on the Risk of Subsequent Symptomatic Malaria in a Longitudinal Cohort in Kenya. eLife, 10, e68812.[CrossRef] [PubMed]
[16] Lindblade, K.A., Steinhardt, L., Samuels, A., Kachur, S.P. and Slutsker, L. (2013) The Silent Threat: Asymptomatic Parasitemia and Malaria Transmission. Expert Review of Anti-infective Therapy, 11, 623-639.[CrossRef] [PubMed]
[17] Sambe, B.S., Sarr, I., Diagne, A., Diatta, A.S., Faye, J., Diagne, N., et al. (2024) Persistent Carriage of Subpatent Plasmodium falciparum Parasites Associated with Clinical Malaria in a Low Transmission Area in Senegal. International Journal of Infectious Diseases, 147, Article ID: 107211.[CrossRef] [PubMed]
[18] Ali, I.M., Manga, I.A., Nji, A.M., Tchuenkam, V.P., Neba, P.T.N., Achu, D.F., et al. (2024) Asymptomatic Plasmodium falciparum Infections and Determinants of Carriage in a Seasonal Malaria Chemoprevention Setting in Northern Cameroon and South Senegal (Kedougou). Malaria Journal, 23, Article No. 386. [Google Scholar] [CrossRef] [PubMed]
[19] Cairns, M., Ceesay, S.J., Sagara, I., Zongo, I., Kessely, H., Gamougam, K., et al. (2021) Effectiveness of Seasonal Malaria Chemoprevention (SMC) Treatments When SMC Is Implemented at Scale: Case-Control Studies in 5 Countries. PLOS Medicine, 18, e1003727.[CrossRef] [PubMed]
[20] Kihwele, F., Gavana, T., Makungu, C., Msuya, H.M., Mlacha, Y.P., Govella, N.J., et al. (2023) Exploring Activities and Behaviours Potentially Increases School-Age Children’s Vulnerability to Malaria Infections in South-Eastern Tanzania. Malaria Journal, 22, Article No. 293.[CrossRef] [PubMed]
[21] Natama, H.M., Moncunill, G., Vidal, M., Rouamba, T., Aguilar, R., Santano, R., et al. (2023) Associations between Prenatal Malaria Exposure, Maternal Antibodies at Birth, and Malaria Susceptibility during the First Year of Life in Burkina Faso. Infection and Immunity, 91, e0026823.
[22] Ceesay, S.J., Koivogui, L., Nahum, A., Taal, M.A., Okebe, J., Affara, M., et al. (2015) Malaria Prevalence among Young Infants in Different Transmission Settings, Africa. Emerging Infectious Diseases, 21, 1114-1121.[CrossRef] [PubMed]
[23] Sarfo, J.O., Amoadu, M., Kordorwu, P.Y., Adams, A.K., Gyan, T.B., Osman, A., et al. (2023) Malaria amongst Children under Five in Sub-Saharan Africa: A Scoping Review of Prevalence, Risk Factors and Preventive Interventions. European Journal of Medical Research, 28, Article No. 80.[CrossRef] [PubMed]
[24] Mbishi, J.V., Chombo, S., Luoga, P., Omary, H.J., Paulo, H.A., Andrew, J., et al. (2024) Malaria in Under-Five Children: Prevalence and Multi-Factor Analysis of High-Risk African Countries. BMC Public Health, 24, Article No. 1687.[CrossRef] [PubMed]
[25] World Health Organization (2025) WHO Guidelines for Malaria. 1-478.
[26] Meremikwu, M.M., Donegan, S., Sinclair, D., Esu, E. and Oringanje, C. (2012) Intermittent Preventive Treatment for Malaria in Children Living in Areas with Seasonal Transmission. Cochrane Database of Systematic Reviews, 2019, CD003756.[CrossRef] [PubMed]
[27] Ouédraogo, A.L., Bousema, T., Schneider, P., de Vlas, S.J., Ilboudo-Sanogo, E., Cuzin-Ouattara, N., et al. (2009) Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission. PLOS ONE, 4, e8410.[CrossRef] [PubMed]
[28] Ojuka, P., Boum, Y., Denoeud-Ndam, L., Nabasumba, C., Muller, Y., Okia, M., et al. (2015) Early Biting and Insecticide Resistance in the Malaria Vector Anopheles Might Compromise the Effectiveness of Vector Control Intervention in Southwestern Uganda. Malaria Journal, 14, Article No. 148.[CrossRef] [PubMed]
[29] Dicko, A., Ouedraogo, J., Zongo, I., Sagara, I., Cairns, M., Yerbanga, R.S., et al. (2024) Seasonal Vaccination with RTS,S/AS01E Vaccine with or without Seasonal Malaria Chemoprevention in Children up to the Age of 5 Years in Burkina Faso and Mali: A Double-Blind, Randomised, Controlled, Phase 3 Trial. The Lancet Infectious Diseases, 24, 75-86.[CrossRef] [PubMed]
[30] Grant, J., Sagara, I., Zongo, I., Cairns, M., Yerbanga, R.S., Diarra, M., et al. (2022) Impact of Seasonal RTS,S/AS01E Vaccination Plus Seasonal Malaria Chemoprevention on the Nutritional Status of Children in Burkina Faso and Mali. Malaria Journal, 21, Article No. 59.[CrossRef] [PubMed]
[31] Perugini, E., Guelbeogo, W.M., Guglielmo, F., Poggi, C., Gabrieli, E., Ranson, H., et al. (2023) The Interplay between Malaria Vectors and Human Activity Accounts for High Residual Malaria Transmission in a Burkina Faso Village with Universal ITN Coverage. Parasites & Vectors, 16, Article No. 101.[CrossRef] [PubMed]
[32] Krezanoski, P.J., Bangsberg, D.R. and Tsai, A.C. (2018) Quantifying Bias in Measuring Insecticide-Treated Bednet Use: Meta-Analysis of Self-Reported vs Objectively Measured Adherence. Journal of Global Health, 8, Article ID: 010411.[CrossRef] [PubMed]
[33] Lindsay, S.W., Thomas, M.B. and Kleinschmidt, I. (2021) Threats to the Effectiveness of Insecticide-Treated Bednets for Malaria Control: Thinking Beyond Insecticide Resistance. The Lancet Global Health, 9, e1325-e1331.[CrossRef] [PubMed]

Copyright © 2026 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.